Thomas B. Ferguson Lecture. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know.
1PCI, used appropriately (including some subsets of multivessel disease and left main stem stenosis) can be a very effective and worthwhile intervention. My criticisms, however, are aimed at its increasing, inappropriate, and non-evidence-based use in the wider population of patients with multivesse...
Главный автор: | Taggart, D |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2006
|
Схожие документы
-
Comparing outcomes between coronary artery bypass grafting and percutaneous coronary intervention in octogenarians with left main or multivessel disease
по: Hristo Kirov, и др.
Опубликовано: (2023-12-01) -
Plastics of the left ventricle aneurysm with minimally invasive multivessel coronary artery bypass grafting
по: V.M. Demianenko, и др.
Опубликовано: (2019-10-01) -
Features of Cardiopulmonary Bypass in Mininvasive Multivessel Coronary Artery Bypass Grafting
по: V. M. Demianenko, и др.
Опубликовано: (2019-05-01) -
Lessons learned from the SYNTAX trial for multivessel and left main stem coronary artery disease.
по: Taggart, D
Опубликовано: (2011) -
Coronary-artery bypass surgery versus stenting for multivessel disease.
по: Taggart, D, и др.
Опубликовано: (2001)